Taxotere

Taxotere is a popular chemotherapy drug that is commonly prescribed to breast cancer. Taxotere has been linked to Alopecia, a disease which causes permanent hair loss. Taxotere manufacturer, Sanofi, failed to warn consumers of all the risks associated with the chemotherapy drug, in some cases even hiding research and evidence from the public. There is currently a number of lawsuits filed on behalf of women who allege they developed Alopecia or experienced similar adverse effects as a result of Taxotere.

Temporary hair loss is a common side effect of most chemotherapy treatments. However, most do not cause a complete loss of hair or hair loss does not become permanent. Studies find that among all of the side effects associated with chemotherapy, temporary hair loss has the greatest impact on a patient’s quality of life. Taxotere has been linked to Alopecia, permanent hair loss, in those who take the drug for chemotherapeutic treatment.

Alopecia is a permanent and irreversible hair loss disease which affects all body hair, including eyebrows, eyelashes, facial hair, and pubic hair. Multiple studies have found that Taxotere use can result in Alopecia.

For breast cancer survivors, Alopecia is more than a cosmetic effect. The disease is a constant reminder of the struggle to fight breast cancer. The 2012 study published in the Annals of Oncology found that women who suffered from Alopecia due to Taxotere suffered “significant impairment” to their quality of life.

Due to the negative effects Taxotere can have on an individual, Neumann Law Group is accepting new cases for women who have experienced permanent thinning or loss of hair following the use of Taxotere.

If you or a loved one has suffered permanent hairloss as a result of using Taxotere, contact the experienced product liability attorneys at Neumann Law Group for a free consultation today.